Development and prospective validation of a machine learning model for risk stratification of drug-induced liver injury using real-world clinical data
Therapeutic Advances in Drug Safety
Published online on July 25, 2026
Abstract
Therapeutic Advances in Drug Safety, Volume 17, January-December 2026.
Background:Drug-induced liver injury (DILI) is difficult to diagnose and manage in routine care because it lacks pathognomonic biomarkers and is often recognized only after clinically meaningful injury has occurred. Existing computational approaches are ...
Background:Drug-induced liver injury (DILI) is difficult to diagnose and manage in routine care because it lacks pathognomonic biomarkers and is often recognized only after clinically meaningful injury has occurred. Existing computational approaches are ...